Patent · US Active

Dosage regimen of paliperidone palmitate extended-release injectable suspension

US12128049B2 · kind B2 · utility

0Cited by

3References

23Claims

0Family size

Assignee

Luye Innomind Pharma Shijiazhuang Co., Ltd. · CN

Inventors

Youxin Li · Langenfeld, DE
Chunjie Sha · Shandong, CN
Fengjuan Zhao · Shandong, CN
Changbing Tu · Shandong, CN
Kaoxiang Sun · Yantai, CN
Wanhui Liu · Yantai, CN
Lifang Sun · Tianjin, CN
Ying Meng · Shandong, CN

Key dates

Filing date	Apr 21, 2023
Grant date	Oct 29, 2024
Priority date	—
Expiry date	Apr 21, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are simplified dosing regimens for administering paliperidone palmitate to a patient in need of treatment of schizophrenia or schizoaffective disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.